Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
British Journal of Haematology, 06/18/2012
Clinical Article
O'Brien S et al. – The findings suggest that elacytarabine has monotherapy activity in patients with advanced acute myeloid leukaemia (AML). This study provides proof–of–concept that lipid esterification of nucleoside analogues is clinically relevant.



